Global Artificial Hearts and Circulatory Assist Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 93
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Ventricular Assist Devices

- Artificial Heart

Segment by Application

- Coronary Heart Disease

- Cerebrovascular Disease

- Peripheral Arterial Disease

- Rheumatic Heart Disease

- Congenital Heart Disease

- Deep Vein Thrombosis

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Medtronic PLC

- Abbott Laboratories

- ABIOMED

- LivaNova PLC

- Berlin Heart

- BiVACOR

- CARMAT

- Jarvik Heart Inc

- SynCardia Systems

- Yongrenxin Medical

Global Artificial Hearts and Circulatory Assist Market Research Report 2022

Table of Contents
1 Artificial Hearts and Circulatory Assist Market Overview
1.1 Product Overview and Scope of Artificial Hearts and Circulatory Assist
1.2 Artificial Hearts and Circulatory Assist Segment by Type
1.2.1 Global Artificial Hearts and Circulatory Assist Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Ventricular Assist Devices
1.2.3 Artificial Heart
1.3 Artificial Hearts and Circulatory Assist Segment by Application
1.3.1 Global Artificial Hearts and Circulatory Assist Sales Comparison by Application: (2022-2028)
1.3.2 Coronary Heart Disease
1.3.3 Cerebrovascular Disease
1.3.4 Peripheral Arterial Disease
1.3.5 Rheumatic Heart Disease
1.3.6 Congenital Heart Disease
1.3.7 Deep Vein Thrombosis
1.3.8 Other
1.4 Global Artificial Hearts and Circulatory Assist Market Size Estimates and Forecasts
1.4.1 Global Artificial Hearts and Circulatory Assist Revenue 2017-2028
1.4.2 Global Artificial Hearts and Circulatory Assist Sales 2017-2028
1.4.3 Artificial Hearts and Circulatory Assist Market Size by Region: 2017 Versus 2021 Versus 2028
2 Artificial Hearts and Circulatory Assist Market Competition by Manufacturers
2.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Manufacturers (2017-2022)
2.2 Global Artificial Hearts and Circulatory Assist Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Artificial Hearts and Circulatory Assist Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Artificial Hearts and Circulatory Assist Manufacturing Sites, Area Served, Product Type
2.5 Artificial Hearts and Circulatory Assist Market Competitive Situation and Trends
2.5.1 Artificial Hearts and Circulatory Assist Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Hearts and Circulatory Assist Players Market Share by Revenue
2.5.3 Global Artificial Hearts and Circulatory Assist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Hearts and Circulatory Assist Retrospective Market Scenario by Region
3.1 Global Artificial Hearts and Circulatory Assist Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Artificial Hearts and Circulatory Assist Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.3.1 North America Artificial Hearts and Circulatory Assist Sales by Country
3.3.2 North America Artificial Hearts and Circulatory Assist Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.4.1 Europe Artificial Hearts and Circulatory Assist Sales by Country
3.4.2 Europe Artificial Hearts and Circulatory Assist Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Hearts and Circulatory Assist Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Hearts and Circulatory Assist Sales by Region
3.5.2 Asia Pacific Artificial Hearts and Circulatory Assist Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.6.1 Latin America Artificial Hearts and Circulatory Assist Sales by Country
3.6.2 Latin America Artificial Hearts and Circulatory Assist Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Hearts and Circulatory Assist Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Hearts and Circulatory Assist Sales by Country
3.7.2 Middle East and Africa Artificial Hearts and Circulatory Assist Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Artificial Hearts and Circulatory Assist Historic Market Analysis by Type
4.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Type (2017-2022)
4.2 Global Artificial Hearts and Circulatory Assist Revenue Market Share by Type (2017-2022)
4.3 Global Artificial Hearts and Circulatory Assist Price by Type (2017-2022)
5 Global Artificial Hearts and Circulatory Assist Historic Market Analysis by Application
5.1 Global Artificial Hearts and Circulatory Assist Sales Market Share by Application (2017-2022)
5.2 Global Artificial Hearts and Circulatory Assist Revenue Market Share by Application (2017-2022)
5.3 Global Artificial Hearts and Circulatory Assist Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Medtronic PLC
6.1.1 Medtronic PLC Corporation Information
6.1.2 Medtronic PLC Description and Business Overview
6.1.3 Medtronic PLC Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Medtronic PLC Artificial Hearts and Circulatory Assist Product Portfolio
6.1.5 Medtronic PLC Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Laboratories Artificial Hearts and Circulatory Assist Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 ABIOMED
6.3.1 ABIOMED Corporation Information
6.3.2 ABIOMED Description and Business Overview
6.3.3 ABIOMED Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ABIOMED Artificial Hearts and Circulatory Assist Product Portfolio
6.3.5 ABIOMED Recent Developments/Updates
6.4 LivaNova PLC
6.4.1 LivaNova PLC Corporation Information
6.4.2 LivaNova PLC Description and Business Overview
6.4.3 LivaNova PLC Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.4.4 LivaNova PLC Artificial Hearts and Circulatory Assist Product Portfolio
6.4.5 LivaNova PLC Recent Developments/Updates
6.5 Berlin Heart
6.5.1 Berlin Heart Corporation Information
6.5.2 Berlin Heart Description and Business Overview
6.5.3 Berlin Heart Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Berlin Heart Artificial Hearts and Circulatory Assist Product Portfolio
6.5.5 Berlin Heart Recent Developments/Updates
6.6 BiVACOR
6.6.1 BiVACOR Corporation Information
6.6.2 BiVACOR Description and Business Overview
6.6.3 BiVACOR Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.6.4 BiVACOR Artificial Hearts and Circulatory Assist Product Portfolio
6.6.5 BiVACOR Recent Developments/Updates
6.7 CARMAT
6.6.1 CARMAT Corporation Information
6.6.2 CARMAT Description and Business Overview
6.6.3 CARMAT Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CARMAT Artificial Hearts and Circulatory Assist Product Portfolio
6.7.5 CARMAT Recent Developments/Updates
6.8 Jarvik Heart Inc
6.8.1 Jarvik Heart Inc Corporation Information
6.8.2 Jarvik Heart Inc Description and Business Overview
6.8.3 Jarvik Heart Inc Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Jarvik Heart Inc Artificial Hearts and Circulatory Assist Product Portfolio
6.8.5 Jarvik Heart Inc Recent Developments/Updates
6.9 SynCardia Systems
6.9.1 SynCardia Systems Corporation Information
6.9.2 SynCardia Systems Description and Business Overview
6.9.3 SynCardia Systems Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.9.4 SynCardia Systems Artificial Hearts and Circulatory Assist Product Portfolio
6.9.5 SynCardia Systems Recent Developments/Updates
6.10 Yongrenxin Medical
6.10.1 Yongrenxin Medical Corporation Information
6.10.2 Yongrenxin Medical Description and Business Overview
6.10.3 Yongrenxin Medical Artificial Hearts and Circulatory Assist Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Yongrenxin Medical Artificial Hearts and Circulatory Assist Product Portfolio
6.10.5 Yongrenxin Medical Recent Developments/Updates
7 Artificial Hearts and Circulatory Assist Manufacturing Cost Analysis
7.1 Artificial Hearts and Circulatory Assist Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Hearts and Circulatory Assist
7.4 Artificial Hearts and Circulatory Assist Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Hearts and Circulatory Assist Distributors List
8.3 Artificial Hearts and Circulatory Assist Customers
9 Artificial Hearts and Circulatory Assist Market Dynamics
9.1 Artificial Hearts and Circulatory Assist Industry Trends
9.2 Artificial Hearts and Circulatory Assist Market Drivers
9.3 Artificial Hearts and Circulatory Assist Market Challenges
9.4 Artificial Hearts and Circulatory Assist Market Restraints
10 Global Market Forecast
10.1 Artificial Hearts and Circulatory Assist Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Type (2023-2028)
10.2 Artificial Hearts and Circulatory Assist Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Application (2023-2028)
10.3 Artificial Hearts and Circulatory Assist Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Hearts and Circulatory Assist by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Artificial Hearts and Circulatory Assist by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Artificial Hearts and Circulatory Assist Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Artificial Hearts and Circulatory Assist Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Artificial Hearts and Circulatory Assist Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Artificial Hearts and Circulatory Assist Market Competitive Situation by Manufacturers in 2021
Table 5. Global Artificial Hearts and Circulatory Assist Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Artificial Hearts and Circulatory Assist Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Artificial Hearts and Circulatory Assist Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Artificial Hearts and Circulatory Assist Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Artificial Hearts and Circulatory Assist Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Artificial Hearts and Circulatory Assist Manufacturing Sites and Area Served
Table 11. Manufacturers Artificial Hearts and Circulatory Assist Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Artificial Hearts and Circulatory Assist by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Hearts and Circulatory Assist as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Artificial Hearts and Circulatory Assist Sales by Region (2017-2022) & (K Units)
Table 16. Global Artificial Hearts and Circulatory Assist Sales Market Share by Region (2017-2022)
Table 17. Global Artificial Hearts and Circulatory Assist Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Artificial Hearts and Circulatory Assist Revenue Market Share by Region (2017-2022)
Table 19. North America Artificial Hearts and Circulatory Assist Sales by Country (2017-2022) & (K Units)
Table 20. North America Artificial Hearts and Circulatory Assist Sales Market Share by Country (2017-2022)
Table 21. North America Artificial Hearts and Circulatory Assist Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Artificial Hearts and Circulatory Assist Revenue Market Share by Country (2017-2022)
Table 23. Europe Artificial Hearts and Circulatory Assist Sales by Country (2017-2022) & (K Units)
Table 24. Europe Artificial Hearts and Circulatory Assist Sales Market Share by Country (2017-2022)
Table 25. Europe Artificial Hearts and Circulatory Assist Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Artificial Hearts and Circulatory Assist Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Artificial Hearts and Circulatory Assist Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Artificial Hearts and Circulatory Assist Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Artificial Hearts and Circulatory Assist Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Artificial Hearts and Circulatory Assist Revenue Market Share by Region (2017-2022)
Table 31. Latin America Artificial Hearts and Circulatory Assist Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Artificial Hearts and Circulatory Assist Sales Market Share by Country (2017-2022)
Table 33. Latin America Artificial Hearts and Circulatory Assist Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Artificial Hearts and Circulatory Assist Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Artificial Hearts and Circulatory Assist Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Artificial Hearts and Circulatory Assist Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Artificial Hearts and Circulatory Assist Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Artificial Hearts and Circulatory Assist Revenue Market Share by Country (2017-2022)
Table 39. Global Artificial Hearts and Circulatory Assist Sales by Type (2017-2022) & (K Units)
Table 40. Global Artificial Hearts and Circulatory Assist Sales Market Share by Type (2017-2022)
Table 41. Global Artificial Hearts and Circulatory Assist Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Artificial Hearts and Circulatory Assist Revenue Share by Type (2017-2022)
Table 43. Global Artificial Hearts and Circulatory Assist Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Artificial Hearts and Circulatory Assist Sales (K Units) by Application (2017-2022)
Table 45. Global Artificial Hearts and Circulatory Assist Sales Market Share by Application (2017-2022)
Table 46. Global Artificial Hearts and Circulatory Assist Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Artificial Hearts and Circulatory Assist Revenue Share by Application (2017-2022)
Table 48. Global Artificial Hearts and Circulatory Assist Price by Application (2017-2022) & (US$/Unit)
Table 49. Medtronic PLC Corporation Information
Table 50. Medtronic PLC Description and Business Overview
Table 51. Medtronic PLC Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Medtronic PLC Artificial Hearts and Circulatory Assist Product
Table 53. Medtronic PLC Recent Developments/Updates
Table 54. Abbott Laboratories Corporation Information
Table 55. Abbott Laboratories Description and Business Overview
Table 56. Abbott Laboratories Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Abbott Laboratories Artificial Hearts and Circulatory Assist Product
Table 58. Abbott Laboratories Recent Developments/Updates
Table 59. ABIOMED Corporation Information
Table 60. ABIOMED Description and Business Overview
Table 61. ABIOMED Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. ABIOMED Artificial Hearts and Circulatory Assist Product
Table 63. ABIOMED Recent Developments/Updates
Table 64. LivaNova PLC Corporation Information
Table 65. LivaNova PLC Description and Business Overview
Table 66. LivaNova PLC Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. LivaNova PLC Artificial Hearts and Circulatory Assist Product
Table 68. LivaNova PLC Recent Developments/Updates
Table 69. Berlin Heart Corporation Information
Table 70. Berlin Heart Description and Business Overview
Table 71. Berlin Heart Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Berlin Heart Artificial Hearts and Circulatory Assist Product
Table 73. Berlin Heart Recent Developments/Updates
Table 74. BiVACOR Corporation Information
Table 75. BiVACOR Description and Business Overview
Table 76. BiVACOR Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. BiVACOR Artificial Hearts and Circulatory Assist Product
Table 78. BiVACOR Recent Developments/Updates
Table 79. CARMAT Corporation Information
Table 80. CARMAT Description and Business Overview
Table 81. CARMAT Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. CARMAT Artificial Hearts and Circulatory Assist Product
Table 83. CARMAT Recent Developments/Updates
Table 84. Jarvik Heart Inc Corporation Information
Table 85. Jarvik Heart Inc Description and Business Overview
Table 86. Jarvik Heart Inc Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Jarvik Heart Inc Artificial Hearts and Circulatory Assist Product
Table 88. Jarvik Heart Inc Recent Developments/Updates
Table 89. SynCardia Systems Corporation Information
Table 90. SynCardia Systems Description and Business Overview
Table 91. SynCardia Systems Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. SynCardia Systems Artificial Hearts and Circulatory Assist Product
Table 93. SynCardia Systems Recent Developments/Updates
Table 94. Yongrenxin Medical Corporation Information
Table 95. Yongrenxin Medical Description and Business Overview
Table 96. Yongrenxin Medical Artificial Hearts and Circulatory Assist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Yongrenxin Medical Artificial Hearts and Circulatory Assist Product
Table 98. Yongrenxin Medical Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Artificial Hearts and Circulatory Assist Distributors List
Table 102. Artificial Hearts and Circulatory Assist Customers List
Table 103. Artificial Hearts and Circulatory Assist Market Trends
Table 104. Artificial Hearts and Circulatory Assist Market Drivers
Table 105. Artificial Hearts and Circulatory Assist Market Challenges
Table 106. Artificial Hearts and Circulatory Assist Market Restraints
Table 107. Global Artificial Hearts and Circulatory Assist Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Artificial Hearts and Circulatory Assist Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Artificial Hearts and Circulatory Assist Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Artificial Hearts and Circulatory Assist Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Artificial Hearts and Circulatory Assist Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Artificial Hearts and Circulatory Assist Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Artificial Hearts and Circulatory Assist Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Artificial Hearts and Circulatory Assist Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Artificial Hearts and Circulatory Assist Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Artificial Hearts and Circulatory Assist Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Artificial Hearts and Circulatory Assist Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Artificial Hearts and Circulatory Assist Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Hearts and Circulatory Assist
Figure 2. Global Artificial Hearts and Circulatory Assist Market Share by Type in 2021 & 2028
Figure 3. Ventricular Assist Devices Product Picture
Figure 4. Artificial Heart Product Picture
Figure 5. Global Artificial Hearts and Circulatory Assist Market Share by Application in 2021 & 2028
Figure 6. Coronary Heart Disease
Figure 7. Cerebrovascular Disease
Figure 8. Peripheral Arterial Disease
Figure 9. Rheumatic Heart Disease
Figure 10. Congenital Heart Disease
Figure 11. Deep Vein Thrombosis
Figure 12. Other
Figure 13. Global Artificial Hearts and Circulatory Assist Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Artificial Hearts and Circulatory Assist Market Size (2017-2028) & (US$ Million)
Figure 15. Global Artificial Hearts and Circulatory Assist Sales (2017-2028) & (K Units)
Figure 16. Artificial Hearts and Circulatory Assist Sales Share by Manufacturers in 2021
Figure 17. Global Artificial Hearts and Circulatory Assist Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Artificial Hearts and Circulatory Assist Players: Market Share by Revenue in 2021
Figure 19. Artificial Hearts and Circulatory Assist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Artificial Hearts and Circulatory Assist Sales Market Share by Region (2017-2022)
Figure 21. Global Artificial Hearts and Circulatory Assist Sales Market Share by Region in 2021
Figure 22. Global Artificial Hearts and Circulatory Assist Revenue Market Share by Region (2017-2022)
Figure 23. Global Artificial Hearts and Circulatory Assist Revenue Market Share by Region in 2021
Figure 24. U.S. Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE Artificial Hearts and Circulatory Assist Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Artificial Hearts and Circulatory Assist by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Artificial Hearts and Circulatory Assist
Figure 50. Manufacturing Process Analysis of Artificial Hearts and Circulatory Assist
Figure 51. Artificial Hearts and Circulatory Assist Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs